Document is current
Any future updates will be listed below
-
Authors
Sim, Sung Hoon
Park, In Hae
Jung, Kyung Hae
Kim, Sung-Bae
Ahn, Jin-Hee
Lee, Kyung-Hun
Im, Seock-Ah https://orcid.org/0000-0002-5396-6533
Im, Young-Hyuck
Park, Yeon Hee
Sohn, Joohyuk
Kim, Yu Jung
Lee, Suee
Kim, Hee-Jun
Chae, Yee Soo
Park, Kyong Hwa
Nam, Byung-Ho
Lee, Keun Seok
Ro, Jungsil
-
Funding
Funding for this research was provided by:
GlaxoSmithKline foundation (1240970-1)
National Cancer Center (1210530)
- License Information
-
More Information
Article History
Received: 13 June 2019
Revised: 7 October 2019
Accepted: 17 October 2019
First Online: 6 November 2019
Competing interests
: The authors declare no competing interests.
: The study protocol and its amendments were approved by the institutional review board of each site (supplementary document). This study was conducted in accordance with the tenets of the Declaration of Helsinki and the provisions of the Good Clinical Practice guidelines (ClinicalTrials.gov number NCT01730677).
: This study was supported by GSK (1240970-1) and Research Grand from National Cancer Center Korea (1210530).
: All informed consents were obtained. This report does not contain any individual person’s information.
: Data supporting the results will be provided on public websites or archives.
